Every day across hospitals and health systems, pharmacists use their specialized knowledge to improve patient outcomes. They work with physicians, nurses and other healthcare team members to help people make the best use of medicines. Learn more about ways they make a difference: https://t.co/puZkRVUhG2 #YourPharmacist
According to this study, neither targeted lecanemab treatment nor treatment unrestricted by APOE ε4 genotype is cost-effective vs standard of care alone for patients with mild cognitive impairment or mild dementia due to Alzheimer disease: https://t.co/PqAihD8JnS
#NeuroTwitter
A narrative review on possible effects of #cannabis, #endocannabinoids, & other lipids in #migraine-related pain finds data from animal models suggesting the endocannabinoid system & CB1 receptor as potential treatment targets
https://t.co/tdqZiRlnTk
R Greco et al
More than 50 million people live with epilepsy worldwide.
A new Review in @TheLancetNeuro discusses causes and diagnostic considerations, highlights the importance of epilepsy classification, and describes emerging investigative tools for diagnosis: https://t.co/1vwSDGE7D2
@PropofolDreamz Stroke risk is still great despite fall risk
https://t.co/sM2TB0tFLj
Truthfully, while some cases may be different, older data with older drugs suggest falling more than once a day for risk to outweigh benefits
https://t.co/UO0vQ2O9TQ
🌟 Elevating Stroke Care Since 2010! Our Marcus Stroke and Neuroscience Center team continues to change how stroke is treated in Atlanta and beyond. Congrats on your latest milestone. 🖐️🎤 #AlwaysInnovating